The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion (Q68209033)
Jump to navigation
Jump to search
scientific article published on 01 November 1987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion |
scientific article published on 01 November 1987 |
Statements
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion (English)
M Castillô
A J Scheen
G Paolisso
P J Lefèbvre
1 November 1987